Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.rec.2020.08.002 http://scihub22266oqcxt.onion/10.1016/j.rec.2020.08.002 32917566!7834732!32917566     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Esp+Cardiol+(Engl+Ed) 2020 ; 73 (12): 994-1002 Nephropedia Template TP {{tp|p=32917566|t=2020. Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience |pdf=|usr=}}{{32917566}} gab.com Text Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience JO: Rev Esp Cardiol (Engl Ed) http://www.kidney.de/pget.php?&tw=1&pmid=32917566 #FOAvip INTRODUCTION AND OBJECTIVES: The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. METHODS: Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. RESULTS: Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P<.001) but showed no differences in the time from first medical contact to reperfusion. In-hospital mortality was higher during COVID-19 (7.5% vs 5.1%; unadjusted OR, 1.50; 95%CI, 1.07-2.11; P <.001); this association remained after adjustment for confounders (risk-adjusted OR, 1.88; 95%CI, 1.12-3.14; P=.017). In the 2020 cohort, there was a 6.3% incidence of confirmed SARS-CoV-2 infection during hospitalization. CONCLUSIONS: The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent. Twit Text FOAVip Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience ????Rev Esp Cardiol (Engl Ed) http://www.kidney.de/pget.php?&tw=1&pmid=32917566 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32917566 #FOAvip English Wikipedia <ref>{{Cite pmid|32917566}}</ref> Impact of COVID-19 on ST-segment elevation myocardial infarction care The Spanish experience #MMPMID32917566 Rodriguez-Leor O; Cid-Alvarez B; Perez de Prado A; Rossello X; Ojeda S; Serrador A; Lopez-Palop R; Martin-Moreiras J; Rumoroso JR; Cequier A; Ibanez B; Cruz-Gonzalez I; Romaguera R; Moreno R; Villa M; Ruiz-Salmeron R; Molano F; Sanchez C; Munoz-Garcia E; Inigo L; Herrador J; Gomez-Menchero A; Gomez-Menchero A; Caballero J; Ojeda S; Cardenas M; Gheorghe L; Oneto J; Morales F; Valencia F; Ruiz JR; Diarte JA; Avanzas P; Rondan J; Peral V; Pernasetti LV; Hernandez J; Bosa F; Lorenzo PLM; Jimenez F; Hernandez JMT; Jimenez-Mazuecos J; Lozano F; Moreu J; Novo E; Robles J; Moreiras JM; Fernandez-Vazquez F; Amat-Santos IJ; Gomez-Hospital JA; Garcia-Picart J; Blanco BGD; Regueiro A; Carrillo-Suarez X; Tizon H; Mohandes M; Casanova J; Agudelo-Montanez V; Munoz JF; Franco J; Del Castillo R; Salinas P; Elizaga J; Sarnago F; Jimenez-Valero S; Rivero F; Oteo JF; Alegria-Barrero E; Sanchez-Recalde A; Ruiz V; Pinar E; Pinar E; Planas A; Ledesma BL; Berenguer A; Fernandez-Cisnal A; Aguar P; Pomar F; Jerez M; Torres F; Garcia R; Frutos A; Nodar JMR; Garcia K; Saez R; Torres A; Telleria M; Sadaba M; Minguez JRL; Merchan JCR; Portales J; Trillo R; Aldama G; Fernandez S; Santas M; Perez MPP Rev Esp Cardiol (Engl Ed) 2020[Dec]; 73 (12): 994-1002 PMID32917566show ga INTRODUCTION AND OBJECTIVES: The COVID-19 outbreak has had an unclear impact on the treatment and outcomes of patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to assess changes in STEMI management during the COVID-19 outbreak. METHODS: Using a multicenter, nationwide, retrospective, observational registry of consecutive patients who were managed in 75 specific STEMI care centers in Spain, we compared patient and procedural characteristics and in-hospital outcomes in 2 different cohorts with 30-day follow-up according to whether the patients had been treated before or after COVID-19. RESULTS: Suspected STEMI patients treated in STEMI networks decreased by 27.6% and patients with confirmed STEMI fell from 1305 to 1009 (22.7%). There were no differences in reperfusion strategy (> 94% treated with primary percutaneous coronary intervention in both cohorts). Patients treated with primary percutaneous coronary intervention during the COVID-19 outbreak had a longer ischemic time (233 [150-375] vs 200 [140-332] minutes, P<.001) but showed no differences in the time from first medical contact to reperfusion. In-hospital mortality was higher during COVID-19 (7.5% vs 5.1%; unadjusted OR, 1.50; 95%CI, 1.07-2.11; P <.001); this association remained after adjustment for confounders (risk-adjusted OR, 1.88; 95%CI, 1.12-3.14; P=.017). In the 2020 cohort, there was a 6.3% incidence of confirmed SARS-CoV-2 infection during hospitalization. CONCLUSIONS: The number of STEMI patients treated during the current COVID-19 outbreak fell vs the previous year and there was an increase in the median time from symptom onset to reperfusion and a significant 2-fold increase in the rate of in-hospital mortality. No changes in reperfusion strategy were detected, with primary percutaneous coronary intervention performed for the vast majority of patients. The co-existence of STEMI and SARS-CoV-2 infection was relatively infrequent. |*Disease Management[MESH] |*Pandemics[MESH] |*Registries[MESH] |*SARS-CoV-2[MESH] |COVID-19/*epidemiology[MESH] |Comorbidity[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Hospital Mortality/trends[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Percutaneous Coronary Intervention/*methods[MESH] |Retrospective Studies[MESH] |ST Elevation Myocardial Infarction/epidemiology/*surgery[MESH]Impact of COVID-19 on ST-segment elevation myocardial infarction care (epmc).pdf DeepDyve Pubget Overpricing